Oral Contraceptives in Reproductive Age Women

April 17, 2019 updated by: Mine Kiseli, Ufuk University

The Awareness About Oral Contraceptives in Reproductive Age Women

Contraception is an important issue in public health; especially when maternal risks and morbidities are considered. There is a need for consciousness about the contraceptive choices. The reproductive age women in Turkey may be stubborn or may choose to believe heath information. The oral contraceptive drugs are not used because of wrong beliefs. This survey study aims to investigate the consciousness and knowledge about the oral contraceptives in 3 different areas in Turkey.

Study Overview

Status

Unknown

Detailed Description

In this study; surveys will be given to reproductive age women admitting to the obstetrics and gynecology departments in 3 different cities of Turkey. Survey questions start with the education and socioeconomical status of the participants. Mainly the questions include the knowledge, ever use about oral contraceptives.

Study Type

Observational

Enrollment (Anticipated)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Karabük, Turkey
        • Recruiting
        • Karabuk University Hospital
        • Contact:
          • Sibel Mutlu
      • Kayseri, Turkey
        • Recruiting
        • Acıbadem Private Hospital
        • Contact:
          • Elif Cinar
    • Çankaya
      • Ankara, Çankaya, Turkey, 06540
        • Recruiting
        • Ufuk University Dr Ridvan Ege Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Reproductive aged women

Description

Inclusion Criteria: The women admitting to the clinics -

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge about oral contraceptives
Time Frame: 6 months of survey study
The number of participants who had knowledge about the correct use of OC pills
6 months of survey study
Contraindications of OC pills
Time Frame: 6 months of survey study
The number of participants who know the contraindications of OC pills /The number of participants who think that OC pills cause infertility
6 months of survey study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge difference in between different regions
Time Frame: 6 months of survey study
The number of participants who had knowledge about the correct use of OC pills in different regions
6 months of survey study
Oral contraceptive use
Time Frame: 6 months of survey study
The number of participants that have ever used oral contraceptive pills
6 months of survey study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Recai Pabuccu, Prof., The Turkish Reproductive Medicine Association

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 2, 2019

Primary Completion (ANTICIPATED)

June 2, 2019

Study Completion (ANTICIPATED)

July 30, 2019

Study Registration Dates

First Submitted

March 16, 2019

First Submitted That Met QC Criteria

April 17, 2019

First Posted (ACTUAL)

April 18, 2019

Study Record Updates

Last Update Posted (ACTUAL)

April 18, 2019

Last Update Submitted That Met QC Criteria

April 17, 2019

Last Verified

April 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • 20180528/4

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe